Made in USA · Research Use Only
Premium research-grade Retatrutide · Made in USA
For research use only. Not for human consumption. Products are intended for laboratory research by qualified professionals.
(Retatrutide) , (LY-3437943, also called Triple G) is a novel triple receptor agonist supplied as a sterile lyophilized powder for laboratory research use only. Each vial of Retatrutide from Neurova is HPLC-tested at ≥98% purity, lot-traceable, and ships with a public Certificate of Analysis. Not for human consumption, diagnostic, or therapeutic use.
RT is investigated in published preclinical and clinical literature as a triple agonist of GLP-1, GIP, and glucagon receptors. Researchers studying incretin pathways, energy expenditure, hepatic lipid metabolism, and receptor pharmacology reference Retatrutide for in-vitro assays, receptor-binding studies, and comparator work alongside other peptide research compounds. The triple-agonist mechanism makes Retatrutide a frequent reference compound in metabolic-pathway investigation protocols.
Store lyophilized vials at -20°C and protect from light. Reconstitute with bacteriostatic water using sterile technique for laboratory protocols. After reconstitution, refrigerate the working solution at 2-8°C and use within the validated stability window for your research method. Always handle in a controlled laboratory environment using appropriate personal protective equipment.
Every Retatrutide lot is independently tested by HPLC for purity and identity. The Certificate of Analysis is publicly available on the product page so research labs can verify lot-specific purity and water-content data before incorporating the material into experimental protocols.
| Compound | Reta (LY-3437943) |
|---|---|
| CAS Number | 2381089-83-2 |
| Molecular Formula | C₂₆₆H₄₀₄N₆₆O₇₇ |
| Molecular Weight | ≈5,989 g/mol |
| Receptor Targets | GLP-1, GIP, Glucagon |
| Form | Sterile lyophilized powder |
| Purity | HPLC ≥ 98% |
| Storage | -20°C, protect from light |
Lab reports and COA documents will be available here in a future update.
Contact us for batch-specific documentation.